United Therapeutics's total assets for Q2 2025 were $7.91B, an increase of 2.12% from the previous quarter. UTHR total liabilities were $734.40M for the fiscal quarter, a -21.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.